What is the extent to which platelet activation in response to infectious agents is reduced following administration of aspirin and ticagrelor in healthy volunteers?
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Aspirin (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 10 Oct 2017 Status changed from not yet recruiting to completed.
- 03 Nov 2016 New trial record